Precipio’s molecular kits use proprietary mutation detection technology that is rapid, cost-effective, and easy-to-use. Our molecular kits can be run on most RT-PCR instruments to identify gene mutations and other variants at low limits of detection.
This technology enables detection of multiple genes of interest (driver mutations) for these blood cancers on a single platform, in a pre-plated assay configuration to further simplify hematopathology workflows.
These molecular kits have been validated as lab developed tests at Precipio’s clinical hematopathology laboratory.
